<VariationArchive VariationID="2627740" VariationName="NM_001378120.1(MBD5):c.4946del (p.Ser1649fs)" VariationType="Deletion" Accession="VCV002627740" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2023-11-11" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2795252" VariationID="2627740">
      <GeneList>
        <Gene Symbol="MBD5" FullName="methyl-CpG binding domain protein 5" GeneID="55777" HGNC_ID="HGNC:20444" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="148020927" stop="148516971" display_start="148020927" display_stop="148516971" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="148778579" stop="149271045" display_start="148778579" display_stop="149271045" Strand="+" />
          </Location>
          <OMIM>611472</OMIM>
          <Haploinsufficiency last_evaluated="2016-08-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MBD5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-08-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MBD5">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001378120.1(MBD5):c.4946del (p.Ser1649fs)</Name>
      <CanonicalSPDI>NC_000002.12:148490577:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="148490578" stop="148490578" display_start="148490578" display_stop="148490578" variantLength="1" positionVCF="148490577" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="149248147" stop="149248147" display_start="149248147" display_stop="149248147" variantLength="1" positionVCF="149248146" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>p.Ser1416Thrfs*12</Name>
      </OtherNameList>
      <ProteinChange>S1416fs</ProteinChange>
      <ProteinChange>S1649fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.149248147del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.149248147del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.148490578del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.148490578del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017003.2" sequenceAccession="NG_017003" sequenceVersion="2" change="g.474568del">
            <Expression>NG_017003.2:g.474568del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017003.3" sequenceAccession="NG_017003" sequenceVersion="3" change="g.474653del">
            <Expression>NG_017003.3:g.474653del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378120.1" sequenceAccession="NM_001378120" sequenceVersion="1" change="c.4946del" MANESelect="true">
            <Expression>NM_001378120.1:c.4946del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365049.1" sequenceAccession="NP_001365049" sequenceVersion="1" change="p.Ser1649fs">
            <Expression>NP_001365049.1:p.Ser1649fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018328.5" sequenceAccession="NM_018328" sequenceVersion="5" change="c.4247del">
            <Expression>NM_018328.5:c.4247del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060798.2" sequenceAccession="NP_060798" sequenceVersion="2" change="p.Ser1416fs">
            <Expression>NP_060798.2:p.Ser1416fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001378120.1(MBD5):c.4946del (p.Ser1649fs) AND Intellectual disability, autosomal dominant 1" Accession="RCV003389030" Version="2">
        <ClassifiedConditionList TraitSetID="242">
          <ClassifiedCondition DB="MedGen" ID="C1969562">Intellectual disability, autosomal dominant 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-11-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-11-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-11-11" MostRecentSubmission="2023-11-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="242" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2886" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 1</ElementValue>
                <XRef ID="MONDO:0007974" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 1</ElementValue>
                <XRef Type="MIM" ID="156200" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611472.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611472.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611472.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611472.0003" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD1</ElementValue>
                <XRef Type="MIM" ID="156200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">MBD5 haploinsufficiency is a neurodevelopmental disorder characterized by developmental delay, intellectual disability, severe speech impairment, seizures, sleep disturbances, and abnormal behaviors. Most children lack speech entirely or have single words, short phrases, or short sentences. Seizures are present in more than 80% of children; onset is usually around age two years. Sleep disturbances, present in about 90%, can result in excessive daytime drowsiness. Abnormal behaviors can include autistic-like behaviors (80%) and self-injury and aggression (&gt;60%).</Attribute>
                <XRef ID="NBK390803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18623" />
                <XRef ID="18623" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27786435</ID>
                <ID Source="BookShelf">NBK390803</ID>
              </Citation>
              <XRef ID="228402" DB="Orphanet" />
              <XRef ID="C1969562" DB="MedGen" />
              <XRef ID="MONDO:0007974" DB="MONDO" />
              <XRef Type="MIM" ID="156200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7680269" SubmissionDate="2023-11-03" DateLastUpdated="2023-11-11" DateCreated="2023-11-11">
        <ClinVarSubmissionID localKey="SUB13952438" submittedAssembly="GRCh37" title="SUB13952438" />
        <ClinVarAccession Accession="SCV004100856" DateUpdated="2023-11-11" DateCreated="2023-11-11" Type="SCV" Version="1" SubmitterName="Clinical Genomics Laboratory, Stanford Medicine" OrgID="507411" OrganizationCategory="laboratory" OrgAbbreviation="CGP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Ser1416Thrfs*12 variant in the MBD5 gene was identified de novo in this individual, but has not been previously reported in association with disease. This variant was absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This variant leads to a premature stop codon in exon 12 of 15, and is therefore predicted to undergo nonsense-medicated decay resulting in a truncated or absent protein. Heterozygous loss of function is an established mechanism of disease for the MBD5 gene. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, there is sufficient evidence to classify the p.Ser1416Thrfs*12 variant as pathogenic for autosomal dominant MBD5-associated neurodevelopmental disorder based on the information above. [ACMG: PVS1, PS2_Supporting; PM2]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MBD5">
              <Name>methyl-CpG binding domain protein 5</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Ser1416Thrfs*12</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018328.4:c.4247delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="156200" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13952438</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7680269" TraitType="Disease" MappingType="XRef" MappingValue="156200" MappingRef="OMIM">
        <MedGen CUI="C1969562" Name="Intellectual disability, autosomal dominant 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

